London Company of Virginia’s AstraZeneca AZN Stock Holding History

London Company of Virginia’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.23M	Hold	6,470	–	–	0.01%	136
2026 Q1	$1.28M	Buy	+6,470	New	+$1.25M	0.01%	137

Other funds holding AZN

Evelyn Partners London $46.9B AUM

Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

London Company of Virginia's AZN Position: Q2 2026 in Review

London Company of Virginia held its AstraZeneca (AZN) position steady in Q2 2026 at 6,470 shares worth $1.23M. The position accounts for 0.01% of the portfolio, ranked #136.

London Company of Virginia first reported a position in AZN in Q1 2026 and has held it in 2 quarters since. The position peaked at $1.28M in Q1 2026. 1,498 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

London Company of Virginia held 6,470 shares of AstraZeneca worth $1.23M as of Q2 2026.
London Company of Virginia left its AstraZeneca share count unchanged in Q2 2026.
AstraZeneca made up 0.01% of London Company of Virginia's portfolio in Q2 2026, its #136 holding.
London Company of Virginia first reported a position in AstraZeneca in Q1 2026 and has held it in 2 quarters since.
London Company of Virginia's AstraZeneca position peaked at $1.28M in Q1 2026.
1,498 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on London Company of Virginia's 13F filing for Q2 2026, filed 14 Aug 2026.